COO – The Cooper Companies, Inc.
Float Short %
4.18
Margin Of Safety %
3
Put/Call OI Ratio
0.73
EPS Next Q Diff
0.64
EPS Last/This Y
2.63
EPS This/Next Y
0.45
Price
84.04
Target Price
90.56
Analyst Recom
2.14
Performance Q
16.44
Upside
-51.1%
Beta
1.02
Ticker: COO
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-01-23 | COO | 81.29 | 0.96 | 0.21 | 5367 |
| 2026-01-26 | COO | 80.89 | 0.96 | 0.14 | 5373 |
| 2026-01-27 | COO | 80.68 | 0.95 | 0.50 | 5433 |
| 2026-01-28 | COO | 80.47 | 0.95 | 0.13 | 5434 |
| 2026-01-29 | COO | 80.37 | 0.94 | 0.43 | 5450 |
| 2026-01-30 | COO | 81.37 | 0.94 | 0.10 | 5451 |
| 2026-02-02 | COO | 80.66 | 0.94 | 0.07 | 5442 |
| 2026-02-04 | COO | 80.94 | 0.91 | 8.84 | 5613 |
| 2026-02-05 | COO | 80.11 | 0.97 | 4.13 | 5794 |
| 2026-02-06 | COO | 82.09 | 1.00 | 0.18 | 5917 |
| 2026-02-09 | COO | 81.48 | 0.99 | 1.00 | 5956 |
| 2026-02-10 | COO | 81.63 | 0.99 | 0.09 | 5967 |
| 2026-02-11 | COO | 83.04 | 0.97 | 0.33 | 6014 |
| 2026-02-12 | COO | 81.69 | 0.97 | 0.00 | 6018 |
| 2026-02-13 | COO | 83.04 | 0.97 | 0.19 | 6025 |
| 2026-02-18 | COO | 83.42 | 0.73 | 0.21 | 7607 |
| 2026-02-19 | COO | 83.68 | 0.73 | 2.33 | 7647 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-01-23 | COO | 81.30 | 11.8 | 102.1 | 4.51 |
| 2026-01-26 | COO | 80.88 | 11.8 | 111.0 | 4.51 |
| 2026-01-27 | COO | 80.69 | 11.8 | 112.7 | 4.51 |
| 2026-01-28 | COO | 80.49 | 11.8 | 112.6 | 4.51 |
| 2026-01-29 | COO | 80.35 | 11.8 | 113.4 | 4.51 |
| 2026-01-30 | COO | 81.40 | 11.8 | 123.2 | 4.51 |
| 2026-02-02 | COO | 80.65 | 11.8 | 108.2 | 4.51 |
| 2026-02-03 | COO | 79.33 | 11.8 | 103.3 | 4.51 |
| 2026-02-04 | COO | 80.94 | 11.8 | 128.2 | 4.51 |
| 2026-02-05 | COO | 80.12 | 11.8 | 107.6 | 4.51 |
| 2026-02-06 | COO | 82.10 | 11.8 | 131.3 | 4.51 |
| 2026-02-09 | COO | 81.48 | 11.8 | 109.4 | 4.51 |
| 2026-02-10 | COO | 81.57 | 11.8 | 115.2 | 4.51 |
| 2026-02-12 | COO | 81.70 | 11.8 | 103.4 | 4.51 |
| 2026-02-18 | COO | 83.43 | 11.8 | 126.6 | 4.51 |
| 2026-02-19 | COO | 83.64 | 11.8 | 116.4 | 4.51 |
| 2026-02-20 | COO | 84.04 | 11.8 | - | 4.51 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-01-23 | COO | 2.62 | 3.46 | 4.06 |
| 2026-01-26 | COO | 2.62 | 3.86 | 4.06 |
| 2026-01-27 | COO | 2.62 | 3.86 | 4.06 |
| 2026-01-28 | COO | 2.62 | 3.86 | 3.72 |
| 2026-01-29 | COO | 2.62 | 3.86 | 3.72 |
| 2026-01-30 | COO | 2.54 | 3.86 | 3.72 |
| 2026-02-02 | COO | 2.54 | 2.63 | 3.72 |
| 2026-02-03 | COO | 2.62 | 2.63 | 3.72 |
| 2026-02-04 | COO | 2.62 | 2.63 | 3.72 |
| 2026-02-05 | COO | 2.62 | 2.63 | 3.72 |
| 2026-02-06 | COO | 2.62 | 2.63 | 3.72 |
| 2026-02-09 | COO | 2.62 | 2.78 | 3.72 |
| 2026-02-10 | COO | 2.62 | 2.78 | 3.72 |
| 2026-02-11 | COO | 2.62 | 2.78 | 4.18 |
| 2026-02-12 | COO | 2.62 | 2.78 | 4.18 |
| 2026-02-13 | COO | 2.62 | 2.78 | 4.18 |
| 2026-02-17 | COO | 2.62 | 7.99 | 4.18 |
| 2026-02-18 | COO | 2.62 | 7.99 | 4.18 |
| 2026-02-19 | COO | 2.62 | 7.99 | 4.18 |
| 2026-02-20 | COO | 2.62 | 7.99 | 4.18 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
0.43
Avg. EPS Est. Current Quarter
1.03
Avg. EPS Est. Next Quarter
1.07
Insider Transactions
2.62
Institutional Transactions
7.99
Beta
1.02
Average Sales Estimate Current Quarter
1023
Average Sales Estimate Next Quarter
1052
Fair Value
86.48
Quality Score
78
Growth Score
84
Sentiment Score
62
Actual DrawDown %
27.5
Max Drawdown 5-Year %
-45.4
Target Price
90.56
P/E
44.86
Forward P/E
16.97
PEG
1.71
P/S
4.03
P/B
2
P/Free Cash Flow
37.99
EPS
1.87
Average EPS Est. Cur. Y
4.51
EPS Next Y. (Est.)
4.96
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
9.16
Relative Volume
0.54
Return on Equity vs Sector %
-24.5
Return on Equity vs Industry %
-6.4
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
The Cooper Companies, Inc.Sector: Healthcare
Industry: Medical Instruments & Supplies
Employees: 15000
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage. This segment offers Paragard, a hormone-free intrauterine device; and fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.
stock quote shares COO – The Cooper Companies, Inc. Stock Price stock today
news today COO – The Cooper Companies, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch COO – The Cooper Companies, Inc. yahoo finance google finance
stock history COO – The Cooper Companies, Inc. invest stock market
stock prices COO premarket after hours
ticker COO fair value insiders trading